company background image
CRON

Cronos Group TSX:CRON Stock Report

Last Price

CA$4.67

Market Cap

CA$1.8b

7D

11.7%

1Y

-12.5%

Updated

04 Dec, 2022

Data

Company Financials +
CRON fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

CRON Stock Overview

Cronos Group Inc. operates as a cannabinoid company.

Rewards

Revenue is forecast to grow 29.11% per year

Risk Analysis

No risks detected for CRON from our risk checks.

Cronos Group Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cronos Group
Historical stock prices
Current Share PriceCA$4.67
52 Week HighCA$5.98
52 Week LowCA$3.32
Beta1.45
1 Month Change12.53%
3 Month Change19.13%
1 Year Change-12.55%
3 Year Change-47.59%
5 Year Change3.78%
Change since IPO462.65%

Recent News & Updates

A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

Oct 12
A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Sep 10
We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Recent updates

A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

Oct 12
A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Sep 10
We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 12
Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

May 19
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?

Jul 29
Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?

An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued

Apr 08
An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued

Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?

Mar 04
Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?

What You Need To Know About Cronos Group Inc.'s (TSE:CRON) Investor Composition

Jan 22
What You Need To Know About Cronos Group Inc.'s (TSE:CRON) Investor Composition

Does Cronos Group's (TSE:CRON) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 18
Does Cronos Group's (TSE:CRON) Statutory Profit Adequately Reflect Its Underlying Profit?

Shareholder Returns

CRONCA PharmaceuticalsCA Market
7D11.7%10.9%0.4%
1Y-12.5%-43.9%1.2%

Return vs Industry: CRON exceeded the Canadian Pharmaceuticals industry which returned -43.9% over the past year.

Return vs Market: CRON underperformed the Canadian Market which returned 1.2% over the past year.

Price Volatility

Is CRON's price volatile compared to industry and market?
CRON volatility
CRON Average Weekly Movement10.0%
Pharmaceuticals Industry Average Movement14.5%
Market Average Movement9.9%
10% most volatile stocks in CA Market18.0%
10% least volatile stocks in CA Market4.1%

Stable Share Price: CRON is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: CRON's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012626Mike Gorensteinhttps://www.thecronosgroup.com

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets.

Cronos Group Inc. Fundamentals Summary

How do Cronos Group's earnings and revenue compare to its market cap?
CRON fundamental statistics
Market CapCA$1.77b
Earnings (TTM)-CA$300.99m
Revenue (TTM)CA$127.69m

13.8x

P/S Ratio

-5.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CRON income statement (TTM)
RevenueUS$94.81m
Cost of RevenueUS$80.67m
Gross ProfitUS$14.15m
Other ExpensesUS$237.63m
Earnings-US$223.49m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.59
Gross Margin14.92%
Net Profit Margin-235.71%
Debt/Equity Ratio0%

How did CRON perform over the long term?

See historical performance and comparison